Yu Xia - 02 Jan 2026 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Adam Finerman, as Attorney-in-Fact for Yu Xia
Issuer symbol
SMMT
Transactions as of
02 Jan 2026
Net transactions value
$0
Form type
4
Filing time
06 Jan 2026, 18:52:50 UTC
Previous filing
23 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Xia Yu Director C/O SUMMIT THERAPEUTICS INC., 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI /s/ Adam Finerman, as Attorney-in-Fact for Yu Xia 06 Jan 2026 0001963544

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +35,000 35,000 02 Jan 2026 Common Stock 35,000 $17.52 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date.
F2 Not applicable.